MYDRIACYL

5% solution instilled into the eyes 15 to 20 minutes prior to examination.

Cycloplegic Refraction:

One or two drops of 1% solution repeated after 5 minutes. If the patient is not seen within 20 to 30 minutes an additional drop may be instilled to prolong the effect.

Use in Children:

Tropicamide has been reported to be inadequate for cycloplegia in children. A more powerful cycloplegic agent such as atropine may be required. 5% in small infants (See section

and section

9 Overdose) Method of administration • For topical ophthalmic use only. • After cap is removed, if tamper evident nap collar is loose, remove before using product. • Nasolacrimal occlusion or gently closing the eyelid after administration is recommended.

This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions. • If more than one topical ophthalmic product is being used, the products must be administered at least 5 minutes apart.

Eye ointments should be administered last. g. Narrow anterior chamber angle). • Hypersensitivity to any component. 4 Special warnings and precautions for use • Tropicamide may cause increased intraocular pressure. The possibility of undiagnosed glaucoma should be considered in some patients, such as elderly patients.

Determine the intraocular pressure and an estimation of the depth of the angle of the anterior chamber prior to initiation of therapy. 8 Undesirable effects). • Extreme caution is advised for use in children and individuals susceptible to belladonna alkaloids because of the increased risk of systemic toxicity.

• Use with caution in an inflamed eye as the hyperaemia greatly increases the rate of systemic absorption through the conjunctiva. To reduce systemic absorption the lacrimal sac should be compressed at the medial can thus by digital pressure for at least two minutes after instillation of the drops.

• Mydriacyl contain benzalkonium chloride which may cause eye irritation and is known to discolour soft contact lenses. Avoid contact with soft contact lenses. Patients must be instructed to remove contact lenses prior to the application of Mydriacyl and wait at least 15 minutes before reinsertion.

• Not for intravenous injection, life threatening adverse reactions have been reported to occur if this preparation is administered intravenously. Paediatric Population • Tropicamide may cause central nervous system disturbances, which may be dangerous in infants and children.

g. Narrow anterior chamber angle). • Hypersensitivity to any component.